Affiliation:
1. Collage of Science, Al-Qasim Green University, Iraq
2. Collage of Veterinary Medicine, Al-Qasim Green University, Iraq
3. Collage of Medicine, University of Al-Ameed, Karbala, Iraq
Abstract
This study was conducted to assess the omentin-1 (OME-1) V109D gene SNP in women with PCOS and healthy control and to investigate the possible relationship between this adipokine and metabolic profile. This study includes 50 women in the range of age (19-43 Y) who have been diagnosed with PCOC as a patient group and 40 healthy women in age (17-45 Y) as a control group. Five ml of peripheral blood were drawn from both groups to perform the biochemical and genetic study. Metabolic profiles were assessed by spectrophotometric methods, and PCR-RFLP investigated V109D of OME-1 SNP. The results suggest a statistical decrease in FBG, BMI, TG, TC, and LDL(p-value<0.05) in the control group compared to the PCOS group and a statistical increase in HDL levels in control compared to the PCOS group. Genotyping analysis shows statistically significant differences between DD and VV genotypes in PCOS and control groups (OR=4.66 (CI 95%,1.6-8.3), (OR=2.4 (CI95%,0.7-6.9) respectively. These results suggest statistically significant differences in three genotypes (DD, DV, and VV) of the PCOS group depending on age and BMI (p-value <0.05). DD and VV genotypes of OME-1 V109D SNP have more risk factors for PCOS incidence and changes in metabolic profile in Iraqi women.
Keywords: Polycystic ovary syndrome, Omentin-1, risk factor, polymorphism genetic
Subject
Infectious Diseases,Applied Microbiology and Biotechnology,Epidemiology,Biotechnology
Reference22 articles.
1. 1- De Leo V, Musacchio MC, Cappelli V, Massaro MG, Morgante G, Petraglia F. Genetic, hormonal and metabolic aspects of PCOS: an update. Reproductive Biology and Endocrinology (Review). 2016; 14 (1): 38.
2. 2- Diamanti-Kandarakis E, Kandarakis H. The role of genes and environment in the etiology of PCOS. Endocrine. 2006; 30 (1): 19–26.
3. 3- Polycystic Ovary Syndrome (PCOS): Condition Information". National Institute of Child Health and Human Development. 31 January, 2017. Retrieved 19 November 2018.
4. 4- Mortada R, Williams T. Metabolic Syndrome: Polycystic Ovary Syndrome. FP Essentials (Review). 2015; 435: 30–42.
5. 5- Giallauria F, Palomba S, Vigorito C, Tafuri MG, Colao A, Lombardi G, Orio F. Androgens in polycystic ovary syndrome: the role of exercise and a diet. Seminars in Reproductive Medicine (Review). 2009;27 (4): 306–15.